Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NASDAQ OMX STOCKHOLM  >  Elekta AB    EKTA B   SE0000163628

ELEKTA AB

(EKTA B)
  Report
Delayed Quote. Delayed NASDAQ OMX STOCKHOLM - 11/27 11:29:52 am
113.25 SEK   +1.12%
11/26ELEKTA : Interim report, May-October 2020/21
AQ
11/26ELEKTA : Gustaf Salford appointed Elekta CEO by Board of Directors
AQ
11/23ELEKTA AB : half-yearly earnings release
 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Omx Stockholm
11/23/2020 11/24/2020 11/25/2020 11/26/2020 11/27/2020 Date
105.6(c) 105.35(c) 106.4(c) 112(c) 113.25(c) Last
1 523 238 1 606 335 1 402 265 2 622 401 2 056 849 Volume
-1.31% -0.24% +1.00% +5.26% +1.12% Change
More quotes
Financials
Sales 2021 14 537 M 1 712 M 1 712 M
Net income 2021 1 402 M 165 M 165 M
Net Debt 2021 1 134 M 134 M 134 M
P/E ratio 2021 30,7x
Yield 2021 1,44%
Sales 2022 15 599 M 1 837 M 1 837 M
Net income 2022 1 619 M 191 M 191 M
Net cash position 2022 29,5 M 3,47 M 3,47 M
P/E ratio 2022 26,9x
Yield 2022 1,69%
Capitalization 43 271 M 5 094 M 5 095 M
EV / Sales 2021 3,05x
EV / Sales 2022 2,77x
Nbr of Employees 4 000
Free-Float 93,7%
More Financials
Company
Elekta AB specializes in the design, manufacturing and marketing of clinical radiosurgery and radiotherapy systems and solutions used in treating cancers and brain disorders. The group also offers software solutions used for image-based management of computerized medical files and for tracking patients' clinical data. Net sales are distributed geographically as follows: Europe/Middle East/Africa (38%), North... 
More about the company
All news about ELEKTA AB
11/26ELEKTA : Interim report, May-October 2020/21
AQ
11/26ELEKTA : Gustaf Salford appointed Elekta CEO by Board of Directors
AQ
11/23ELEKTA AB : half-yearly earnings release
11/19ELEKTA : With Elekta Studio, Elekta brings complete image-guided brachytherapy w..
AQ
11/11ELEKTA : Invitation to the presentation of Elekta's second quarter 2020/21
PU
11/11ELEKTA : Invitation to the presentation of Elekta's second quarter 2020/21
AQ
11/06ELEKTA : newest radiotherapy system, Elekta Harmony, receives CE mark
AQ
11/04ELEKTA : Nomination Committee for the 2021 Annual General Meeting
PU
11/04ELEKTA : Nomination Committee for the 2021 Annual General Meeting
AQ
09/25ELEKTA : early out in securing MDR certificates for its linac portfolio
AQ
09/15ELEKTA : introduces new radiotherapy solution to help address worldwide cancer b..
PU
09/15ELEKTA : introduces new radiotherapy solution to help address worldwide cancer b..
AQ
09/07ELEKTA : Invitation to attend the virtual launch of Elekta's new linear accelera..
AQ
08/27ELEKTA AB : Ex-dividend day for final dividend
FA
08/26GLOBAL MARKETS LIVE: Royal Bank of Canada, Hewlett Packard, Salesforce…
More news
News in other languages on ELEKTA AB
11/26EN DIRECT DES MARCHES : Orange / Atos, Alstom, Unibail, Europcar, CGG, Slack, De..
11/23Thanksgiving et Covid ne font pas bon ménage
11/23AVIS D'ANALYSTES DU JOUR : ASML, BMW, Crédit Suisse, Genmab, HelloFresh, Orsted,..
11/23ELEKTA AB : publication des résultats semestriels
11/23ELEKTA AB : Veröffentlichung des Halbjahresergebnisses
More news
Chart ELEKTA AB
Duration : Period :
Elekta AB Technical Analysis Chart | EKTA B | SE0000163628 | MarketScreener
Technical analysis trends ELEKTA AB
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 14
Average target price 110,60 SEK
Last Close Price 113,25 SEK
Spread / Highest target 45,7%
Spread / Average Target -2,34%
Spread / Lowest Target -40,8%
EPS Revisions
Managers
NameTitle
Gustaf Salford President & Chief Executive Officer
Laurent Leksell Chairman
Steven Mark Wort Chief Operating Officer
John Adebäck Chief Financial Officer & Group Treasurer
Jane M. Birgitta Göransson Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
ELEKTA AB-8.19%5 094
CERNER CORPORATION0.97%22 718
PERKINELMER, INC.33.12%14 474
GN STORE NORD A/S60.04%10 378
BRUKER CORPORATION-0.61%7 756
LIFETECH SCIENTIFIC CORPORATION102.01%1 827